Traditional in-person clinical symptom assessments in trials can be burdensome for patients and expensive for trial sponsors. These measures are limited by rater subjectivity and variability, lower frequency, and how accurately the participant's clinical presentation at the site represents their true day-to-day functioning. Learn how to eliminate these blind spots by tracking digital biomarkers and creating more frequent check-ins that take place in the comfort of a patient’s home, providing more accurate patient data.
Join Isaac Galatzer-Levy PhD, Chief Scientific Officer, to learn how:
- Sponsors can access real-time, accurate patient data to enable more powerful insights.
- Sites can continue to provide care, with the ability to stay closely connected to patients and monitor them in their own homes.
- Patients can stay on track with medication and be safely monitored.